51
|
Yu X, Huang L, Wei Y, Yang Q, Liu H, Yao B. Preparation and performance of Cu2O/TiO2 nano-thin film for photocatalytic degradation of methylene blue. ACTA ACUST UNITED AC 2015. [DOI: 10.1179/1433075x15y.0000000011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Affiliation(s)
- X. Yu
- Department of Applied Chemistry, Xi'an University of Technology, Xi'an710048, China
| | - L. Huang
- Department of Applied Chemistry, Xi'an University of Technology, Xi'an710048, China
| | - Y. Wei
- Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
| | - Q. Yang
- Department of Applied Chemistry, Xi'an University of Technology, Xi'an710048, China
| | - H. Liu
- School of Science, Xi'an Polytechnic University, Xi'an710048, China
| | - B. Yao
- Department of Applied Chemistry, Xi'an University of Technology, Xi'an710048, China
| |
Collapse
|
52
|
Du X, Yao B, Gonzalez-Cortes S, Kuznetsov VL, AlMegren H, Xiao T, Edwards PP. Catalytic dehydrogenation of propane by carbon dioxide: a medium-temperature thermochemical process for carbon dioxide utilisation. Faraday Discuss 2015; 183:161-76. [DOI: 10.1039/c5fd00062a] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The dehydrogenation of C3H8 in the presence of CO2 is an attractive catalytic route for C3H6 production. In studying the various possibilities to utilise CO2 to convert hydrocarbons using the sustainable energy source of solar thermal energy, thermodynamic calculations were carried out for the dehydrogenation of C3H8 using CO2for the process operating in the temperature range of 300–500 °C. Importantly, the results highlight the enhanced potential of C3H8 as compared to its lighter and heavier homologues (C2H6 and C4H10, respectively). To be utilised in this CO2 utilisation reaction the Gibbs free energy (ΔrGθm) of each reaction in the modelled, complete reacting system of the dehydrogenation of C3H8 in the presence of CO2 also indicate that further cracking of C3H6 will affect the ultimate yield and selectivity of the final products. In a parallel experimental study, catalytic tests of the dehydrogenation of C3H8 in the presence of CO2 over 5 wt%-Cr2O3/ZrO2 catalysts operating at 500 °C, atmospheric pressure, and for various C3H8 partial pressures and various overall GHSV (Gas Hourly Space Velocity) values. The results showed that an increase in the C3H8 partial pressure produced an inhibition of C3H8 conversion but, importantly, a promising enhancement of C3H6 selectivity. This phenomenon can be attributed to competitive adsorption on the catalyst between the generated C3H6 and inactivated C3H8, which inhibits any further cracking effect on C3H6 to produce by-products. As a comparison, the increase of the overall GHSV can also decrease the C3H8 conversion to a similar extent, but the further cracking of C3H6 cannot be limited.
Collapse
Affiliation(s)
- X. Du
- King Abdulaziz City of Science and Technology (KACST) – Oxford Centre of Excellence in Petrochemicals
- Inorganic Chemistry Laboratory
- Department of Chemistry
- University of Oxford
- Oxford
| | - B. Yao
- SINOPEC Shanghai Petrochemical Company LTD
- Shanghai
- China
| | - S. Gonzalez-Cortes
- King Abdulaziz City of Science and Technology (KACST) – Oxford Centre of Excellence in Petrochemicals
- Inorganic Chemistry Laboratory
- Department of Chemistry
- University of Oxford
- Oxford
| | - V. L. Kuznetsov
- King Abdulaziz City of Science and Technology (KACST) – Oxford Centre of Excellence in Petrochemicals
- Inorganic Chemistry Laboratory
- Department of Chemistry
- University of Oxford
- Oxford
| | - Hamid AlMegren
- Petrochemicals Research Institute (PRI)
- King Abdulaziz City of Science and Technology (KACST)
- Riyadh 11442
- Saudi Arabia
| | - T. Xiao
- King Abdulaziz City of Science and Technology (KACST) – Oxford Centre of Excellence in Petrochemicals
- Inorganic Chemistry Laboratory
- Department of Chemistry
- University of Oxford
- Oxford
| | - P. P. Edwards
- King Abdulaziz City of Science and Technology (KACST) – Oxford Centre of Excellence in Petrochemicals
- Inorganic Chemistry Laboratory
- Department of Chemistry
- University of Oxford
- Oxford
| |
Collapse
|
53
|
Lu JC, Jing J, Dai JY, Zhao AZ, Yao Q, Fan K, Wang GH, Liang YJ, Chen L, Ge YF, Yao B. Body mass index, waist-to-hip ratio, waist circumference and waist-to-height ratio cannot predict male semen quality: a report of 1231 subfertile Chinese men. Andrologia 2014; 47:1047-54. [PMID: 25418484 DOI: 10.1111/and.12376] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/23/2014] [Indexed: 12/29/2022] Open
Affiliation(s)
- J.-C. Lu
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
- Department of Laboratory Science, Nanjing Hospital, Jiangsu Corps; The Armed Police Force; PLA; Nanjing China
| | - J. Jing
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
| | - J.-Y. Dai
- Key Laboratory of Animal Ecology and Conservation Biology; Institute of Zoology; Chinese Academy of Sciences; Beijing China
| | - A. Z. Zhao
- Department of Gerontology; the First Affiliated Hospital; and the Center of Metabolic Disease Research; Nanjing Medical University; Nanjing China
| | - Q. Yao
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
| | - K. Fan
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
| | - G.-H. Wang
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
| | - Y.-J. Liang
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
| | - L. Chen
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
| | - Y.-F. Ge
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
| | - B. Yao
- Reproductive Medical Center; Nanjing Jinling Hospital; Nanjing University School of Medicine; Nanjing China
| |
Collapse
|
54
|
Li Z, Huang H, Zhao H, Meng K, Zhao J, Shi P, Yang P, Luo H, Wang Y, Yao B. Genetic diversity and expression profiles of cysteine phytases in the sheep rumen during a feeding cycle. Lett Appl Microbiol 2014; 59:615-20. [PMID: 25146240 DOI: 10.1111/lam.12318] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2014] [Revised: 08/11/2014] [Accepted: 08/15/2014] [Indexed: 11/29/2022]
Abstract
UNLABELLED Cysteine phytase is the main phytate-degrading enzyme of ruminant animals. To explore the genetic diversity and dynamic expression profile of cysteine phytase in sheep rumen during a feeding cycle, four transcript (0, 4, 9 and 16 h after feeding) and one DNA (9 h after feeding) clone libraries were constructed, respectively. A total of 46 distinct gene fragments were identified, and most of these sequences had low identities (<60%) with known phytases. Great divergence was found in the constitution and abundance of genes at the genome and transcriptional levels, and the transcript data are more reliable to reflect the information of functional genes. Phylogenetic analysis indicated that the genes from uncultured bacteria instead of Firmicutes played the major phytate-degrading role. Further comparative analysis revealed the dynamic constitution of cysteine phytase genes in rumen at different time points. SIGNIFICANCE AND IMPACT OF THE STUDY Ruminal phytases, that are cysteine phytases, are novel in sequences and functions. Great divergence in the constitution and abundance of cysteine phytase genes at the genome and transcriptional levels suggested that transcript data are more reliable to reflect the information of functional genes. Phylogenetic and rarefaction analyses indicated that the cysteine phytase genes from uncultured bacteria instead of Firmicutes play the major phytate-degrading role in rumen, and their constitution is dynamic at different time points. This study provides a new insight into ruminal cysteine phytase genes and undermines their expression profiles over a whole feeding cycle.
Collapse
Affiliation(s)
- Z Li
- Key Laboratory for Feed Biotechnology of the Ministry of Agriculture, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China; Key Laboratory of Industrial Fermentation Microbiology, Tianjin University of Science and Technology, Tianjin, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
55
|
Besse B, Soria JC, Yao B, Kris M, Chao B, Cortot A, Mazieres J, Socinski M, Horn L, Waqar S, Barlesi F, Gray J, Moro-Sibilot D, Oton A, Quoix E, Lalani A, McCulloch L, Bryce R, Gandhi L. Neratinib (N) with or Without Temsirolimus (Tem) in Patients (Pts) with Non-Small Cell Lung Cancer (Nsclc) Carrying Her2 Somatic Mutations: an International Randomized Phase Ii Study. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu438.47] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
56
|
Bogni L, Dje K, Yao B, Coulibaly N, Akassimadou N, Avion K. Les enterocystoplasties dans le traitement du cancer de la vessie en cote d’ivoire: Quelle faisabilité? Quels résultats? (A propos de 18 observations). African Journal of Urology 2014. [DOI: 10.1016/j.afju.2014.03.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
57
|
Dje K, Yao B, Coulibaly N, Akassimadou N, Bogni P. Retention aigue d’urines sur vessie ptosee post-traumatique: a propos d’une observation et revue de la littérature. African Journal of Urology 2014. [DOI: 10.1016/j.afju.2014.03.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
58
|
Kubota K, Ichinose Y, Scagliotti G, Spigel D, Kim JH, Shinkai T, Takeda K, Kim SW, Hsia TC, Li RK, Tiangco BJ, Yau S, Lim WT, Yao B, Hei YJ, Park K. Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis. Ann Oncol 2014; 25:529-36. [PMID: 24419239 DOI: 10.1093/annonc/mdt552] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND This preplanned subset analysis of the phase III MONET1 study aimed to determine whether motesanib combined with carboplatin/paclitaxel (C/P) would result in improved overall survival (OS) versus chemotherapy alone, in a subset of Asian patients with nonsquamous nonsmall-cell lung cancer (NSCLC). PATIENTS AND METHODS Patients with nonsquamous NSCLC (stage IIIB/IV or recurrent) and no prior systemic therapy for advanced disease were randomized to IV carboplatin (AUC, 6 mg/ml min) and paclitaxel (200 mg/m2) for up to six 3-week cycles, plus either oral motesanib 125 mg q.d. or placebo. Primary end point was OS; secondary end points included progression-free survival (PFS), objective response rate (ORR), and safety. RESULTS Two hundred twenty-seven Asian patients from MONET1 were included in this descriptive analysis. Median OS was 20.9 months in the motesanib plus C/P arm and 14.5 months in the placebo plus C/P arm (P=0.0223); median PFS was 7.0 and 5.3 months, respectively, (P=0.0004); and ORR was 62% and 27%, respectively, (P<0.0001). Grade≥3 adverse events were more common in the motesanib plus C/P arm versus placebo plus C/P (79% versus 61%). CONCLUSION In this preplanned subset analysis of Asian patients with nonsquamous NSCLC, motesanib plus C/P significantly improved OS, PFS, and ORR versus placebo plus C/P. CLINICAL TRIAL NUMBER NCT00460317.
Collapse
Affiliation(s)
- K Kubota
- Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
59
|
Yao B, Chen X, Shen FX, Xu W, Dong TT, Chen LZ, Weng JP. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. Transplant Proc 2013; 45:194-6. [PMID: 23375298 DOI: 10.1016/j.transproceed.2012.08.019] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2009] [Revised: 06/20/2012] [Accepted: 08/28/2012] [Indexed: 01/28/2023]
Abstract
BACKGROUND Posttransplantation diabetes mellitus (PTDM) is a common, serious complication of kidney transplantation. The purpose of this study was to investigate the incidence of and risk factors for PTDM in relationship to Fok1 vitamin D receptor (VDR) polymorphisms. METHODS One hundred five kidney transplant recipients with normal glucose values before transplantation were recruited for this study. All patients underwent fasting plasma glucose (FPG) determinations followed by oral glucose tolerance tests (OGTTs) among normal FPG recipients. Every recipient underwent Fok1 VDR polymorphism analysis using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). RESULTS Among 105 recipients, 16 (15.24%) developed new-onset PTDM within 6 months after kidney transplantation. Compared with 89 non-PTDM recipients, the mean age was significantly higher among recipients with PTDM: 47.81 ± 15.54 vs 36.62 ± 11.43 years (P = .001). Patients treated with tacrolimus were more susceptible to PTDM (56.25% vs 28.09%; P = .027). The distribution frequencies of Fok1 genotypes in this cohort followed the Hardy-Weinberg equilibrium. The frequencies of 3 genotypes (FF/Ff/ff; P = .040) and 2 alleles (F/f; P = .009) differed between the 2 groups. Multivariate analysis by logistic regression showed age older than 40 years (odds ratio, 7.774; P = .005), VDR Fok1 f allele (odds ratio, 11.765; P = .012), and tacrolimus therapy (odds ratio, 7.499; P = .007) to be related to the development of PTDM. CONCLUSIONS The incidence of newly diagnosed PTDM in this study was 15.24%. Fok1 VDR polymorphism was a genetic marker predicting PTDM risk. Age older than 40 years and tacrolimus were independent risk factors for PTDM.
Collapse
Affiliation(s)
- B Yao
- Department of Endocrinology, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
| | | | | | | | | | | | | |
Collapse
|
60
|
Darbal AD, Ganesh KJ, Liu X, Lee SB, Ledonne J, Sun T, Yao B, Warren AP, Rohrer GS, Rollett AD, Ferreira PJ, Coffey KR, Barmak K. Grain boundary character distribution of nanocrystalline Cu thin films using stereological analysis of transmission electron microscope orientation maps. Microsc Microanal 2013; 19:111-119. [PMID: 23380005 DOI: 10.1017/s1431927612014055] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Stereological analysis has been coupled with transmission electron microscope (TEM) orientation mapping to investigate the grain boundary character distribution in nanocrystalline copper thin films. The use of the nanosized (<5 nm) beam in the TEM for collecting spot diffraction patterns renders an order of magnitude improvement in spatial resolution compared to the analysis of electron backscatter diffraction patterns in the scanning electron microscope. Electron beam precession is used to reduce dynamical effects and increase the reliability of orientation solutions. The misorientation distribution function shows a strong misorientation texture with a peak at 60°/[111], corresponding to the Σ3 misorientation. The grain boundary plane distribution shows {111} as the most frequently occurring plane, indicating a significant population of coherent twin boundaries. This study demonstrates the use of nanoscale orientation mapping in the TEM to quantify the five-parameter grain boundary distribution in nanocrystalline materials.
Collapse
Affiliation(s)
- A D Darbal
- Materials Research Science and Engineering Center, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, PA 15213, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
61
|
Yang B, Sun H, Wan Y, Wang H, Qin W, Yang L, Zhao H, Yuan J, Yao B. Associations between testosterone, bone mineral density, vitamin D and semen quality in fertile and infertile Chinese men. ACTA ACUST UNITED AC 2012; 35:783-792. [PMID: 22713128 DOI: 10.1111/j.1365-2605.2012.01287.x] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Testosterone (T) and vitamin D (VD) interact in androgen deficient men, however, this interaction and subsequent semen quality and bone mineral density (BMD) status is not clear in infertile men. Our objective was to investigate T, VD, semen quality, BMD and their relationships in Chinese infertile men. We conducted a cross-sectional study of 559 men aged 20-40 years, including 195 fertile men, 9 infertile men with known risk factors for osteoporosis (WR) and 355 infertile men without known risk factors for osteoporosis (WOR). WOR infertile men constituted 314 oligo-, astheno-, teratospermic or normospermic infertile men (OATN men) and 41 non-obstructive azoospermic men (NOA men). Differences of parameters were assessed, and the relationships were adjusted by multiple linear regression. WOR infertile men had significantly lower T, lumbar spine and total hip BMD than fertile men (all p < 0.05). Bioavailable T (Bio-T) and 25-hydroxyvitamin D [25(OH)D] were independent determinants of BMD in WOR infertile men (all p < 0.01) but not in fertile men. After stratifying Bio-T, WOR infertile men had lower BMD than fertile men (all p < 0.05) in low Bio-T subgroups (Bio-T ≤ 11.6 nmol/L), but not high Bio-T subgroups (Bio-T > 11.6 nmol/L). 25(OH)D was an independent determinant of sperm motility and morphology in WOR OATN men (all p < 0.05), with only borderline significance in fertile men(motility: p = 0.047; morphology: p = 0.056). T determined sperm concentration (square root) and morphology in WOR OATN men (all p < 0.001). No correlations between T and 25(OH)D were found in all groups. We suggest that infertile men have lower T and BMD than fertile men. 25(OH)D and T were associated with low BMD and poor semen quality in infertile men.
Collapse
Affiliation(s)
- B Yang
- Institute of Clinical Laboratory Medicine, Nanjing Jinling Hospital, Clinical School of Medical College, Nanjing University, Nanjing, China
| | | | | | | | | | | | | | | | | |
Collapse
|
62
|
Pan ZB, Yao B, Yu HH, Xu HH, Wang ZP, Wang JY, Zhang HJ. Growth and characterization of self-Q-switched Nd:Cr:YVO4 crystal. Opt Express 2012; 20:2178-2183. [PMID: 22330458 DOI: 10.1364/oe.20.002178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
A Nd:Cr:YVO4 crystal was grown by the Czochralski method for the first time to our knowledge. Its structure and cell parameter have been studied by X-ray powder diffraction (XRPD) analysis. Polarized absorption spectra were measured at room temperature, which showed that the absorption bands display polarization character and an absorption band of Cr5+ ions at 1110 nm enables the crystal to be a self-Q-switched laser material. We also found that the absorption of Cr5+ ions became much larger and its self-Q-switched laser performance became much better when the Nd:Cr:YVO4 crystal was annealed because the annealing induces more Cr ions to become those with + 5 valence. In the self-Q-switched laser, the maximum output power, shortest pulse width, and largest pulse energy were obtained to be 120 mW, 85.8 ns, and 0.79 μJ, respectively.
Collapse
Affiliation(s)
- Z B Pan
- State Key Laboratory of Crystal Materials and Institute of Crystal Materials, Shandong University, Jinan 250100, China
| | | | | | | | | | | | | |
Collapse
|
63
|
Xing G, Wang D, Yao B, Lloyd Foong Nien A, Yan Y. Structural characteristics, low threshold ultraviolet lasing and ultrafast carrier dynamics in high crystalline ZnO nanowire arrays. Chem Phys Lett 2011. [DOI: 10.1016/j.cplett.2011.09.007] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
64
|
Zang H, Zhang K, Ding X, Bai S, Hernández JM, Yao B. Effects of different dietary vitamin combinations on the egg quality and vitamin deposition in the whole egg of laying hens. Rev Bras Cienc Avic 2011. [DOI: 10.1590/s1516-635x2011000300005] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- H Zang
- Sichuan Agricultural University, China
| | - K Zhang
- Sichuan Agricultural University, China
| | - X Ding
- Sichuan Agricultural University, China
| | - S Bai
- Sichuan Agricultural University, China
| | | | | |
Collapse
|
65
|
Zhang W, Zhang KY, Ding XM, Bai SP, Hernandez JM, Yao B, Zhu Q. Influence of canthaxanthin on broiler breeder reproduction, chick quality, and performance. Poult Sci 2011; 90:1516-22. [PMID: 21673167 DOI: 10.3382/ps.2010-01126] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
To investigate the effect of canthaxanthin supplied via a maternal route on the production of both breeder hens and chickens, 270 Chinese Three-Yellow breeder hens were randomly divided into 2 groups consisting of 135 birds each (5 replicates of 27) for study. The breeder hens were fed either a basal diet or the basal diet supplemented with 6 mg of canthaxanthin/kg for 24 wk. At the end of the 24-wk breeder experiment, all hatching eggs laid in 5 consecutive days of each group were collected and incubated. For each breeder group, 100 newly hatched chicks (5 replicates of 20) were reared under environmentally controlled conditions for 21 d. Canthaxanthin supplementation resulted in the following outcomes: an enhancement of the serum total antioxidant capacity (TAC) of breeder hens (P = 0.029), a significant increase in the yolk colorimetric score of Roche Yolk Color Fan (RYCF; P < 0.001), and a significant improvement of the antioxidant status of the egg yolk (P < 0.05). The chicks that hatched from eggs laid by breeder hens fed the canthaxanthin supplementation diet demonstrated a higher pigmentation colorimetric score of RYCF for their shank skin (P < 0.05), and the antioxidant capacity of the newly hatched chicks was significantly increased (P < 0.05). Both of these positive effects on shank skin pigmentation colorimetric score of RYCF and antioxidant capacity were observed for at least 7 d posthatching, and the chicks that hatched from canthaxanthin-enriched eggs showed a lower mortality (0 vs. 4%) during the first 21 d posthatching. These findings support the hypothesis that canthaxanthin supplementation of the maternal diet enhances the protective capacity of tissues against oxidative stress in vivo, which might be beneficial for poultry producers.
Collapse
Affiliation(s)
- W Zhang
- Institute of Animal Nutrition, Sichuan Agricultural University, Ya'an, Sichuan, People's Republic of China
| | | | | | | | | | | | | |
Collapse
|
66
|
Scagliotti G, Vynnychenko I, Ichinose Y, Park K, Kubota K, Blackhall FH, Pirker R, Galiulin R, Ciuleanu T, Sydorenko O, Dediu M, Papai-Szekely Z, Martinez Banaclocha N, McCoy S, Yao B, Hei YJ, Spigel DR. An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.18_suppl.lba7512] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
LBA7512 Background: This study evaluated whether motesanib (a selective oral inhibitor of VEGFR 1, 2 and 3; PDGFR and Kit) plus C/P improved overall survival (OS) compared with placebo + C/P in patients (pts) with nonsquamous NSCLC and in a subset of pts with adenocarcinoma. Methods: Pts had stage IIIB/IV or recurrent nonsquamous NSCLC and no prior systemic therapy for advanced NSCLC. The study initially enrolled all histologies but was amended to exclude pts with squamous NSCLC owing to a high rate of hemoptysis. Pts were randomized 1:1 to receive up to six 3-wk cycles of C (AUC 6 mg/mL·min) and P (200 mg/m2) with either motesanib 125 mg QD (Arm A) or placebo QD (Arm B) orally continuously. The primary endpoint was OS; secondary endpoints included progression-free survival (PFS), adverse events (AEs), objective response rate (ORR) and association between placental growth factor (PLGF) change and OS. OS was evaluated using a stratified Cox model and 2-sided log-rank test (α=0.03 for nonsquamous pts and α=0.02 for adenocarcinoma pts). Results: 1090 pts with nonsquamous NSCLC were randomized (Arm A/B, n=541/549); 890 had adenocarcinoma (n=448/442). 61% were men; median age was 60 years (range 21–87); 83% had stage IV disease. At the time of analysis, 753 pts had died (608 pts with adenocarcinoma). Median follow-up was 10.6 mo. OS was not significantly improved in Arm A compared with Arm B (Table). In Arm A, PLGF analysis did not show an association with OS. The incidence of grade ≥3 AEs in Arms A/B was 73/59%. Grade ≥3 AEs occurring more frequently in Arm A than B included neutropenia (22/15%), diarrhea (9/1%), hypertension (7/1%) and cholecystitis (3/0%). The incidence of grade 5 AEs was 14/9% in Arms A/B. Conclusions: In pts with advanced nonsquamous NSCLC, treatment with motesanib + C/P did not significantly improve OS compared with C/P alone. [Table: see text]
Collapse
Affiliation(s)
- G. Scagliotti
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - I. Vynnychenko
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - Y. Ichinose
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - K. Park
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - K. Kubota
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - F. H. Blackhall
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - R. Pirker
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - R. Galiulin
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - T. Ciuleanu
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - O. Sydorenko
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - M. Dediu
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - Z. Papai-Szekely
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - N. Martinez Banaclocha
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - S. McCoy
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - B. Yao
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - Y. J. Hei
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| | - D. R. Spigel
- Department of Clinical and Biological Sciences, University of Turin, S. Luigi Hospital, Turin, Italy; Sumy Regional Oncology Centre, Sumy, Ukraine; National Kyushu Cancer Center, Fukuoka, Japan; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; National Cancer Center, Tokyo, Japan; Department of Medical Oncology, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Department of Medicine I, Medical University Vienna, Vienna, Austria
| |
Collapse
|
67
|
Scagliotti G, Vynnychenko I, Ichinose Y, Park K, Kubota K, Blackhall FH, Pirker R, Galiulin R, Ciuleanu T, Sydorenko O, Dediu M, Papai-Szekely Z, Martinez Banaclocha N, McCoy S, Yao B, Hei YJ, Spigel DR. An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.lba7512] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
68
|
He S, Zhou Z, Meng K, Zhao H, Yao B, Ringø E, Yoon I. Effects of dietary antibiotic growth promoter and Saccharomyces cerevisiae fermentation product on production, intestinal bacterial community, and nonspecific immunity of hybrid tilapia (Oreochromis niloticus female × Oreochromis aureus male)1. J Anim Sci 2011; 89:84-92. [DOI: 10.2527/jas.2010-3032] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
69
|
Cui YX, Wei L, Xia XY, Fan XB, Shi YC, Yao B, Ge YF, Li XJ, Huang YF. Meiotic Pairing Error in an Infertile Male Bearing Reciprocal Deletion of Chromosome 13. ACTA ACUST UNITED AC 2010; 32:473-7. [DOI: 10.2164/jandrol.109.009738] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
70
|
Yao B, Jiang BR, Ai HS, Li YF, Liu GX, Man QH, Qiu LJ. Biological dose estimation for two severely exposed patients in a radiation accident in Shandong Jining, China, in 2004. Int J Radiat Biol 2010; 86:800-8. [PMID: 20636236 DOI: 10.3109/09553002.2010.481320] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- B. Yao
- Department of Radiation Medicine and Clinical Hematology, the 307 Hospital, Beijing, P. R. China
| | - B. R. Jiang
- Department of Radiation Medicine and Clinical Hematology, the 307 Hospital, Beijing, P. R. China
| | - H. S. Ai
- Department of Radiation Medicine and Clinical Hematology, the 307 Hospital, Beijing, P. R. China
| | - Y. F. Li
- Department of Radiation Medicine and Clinical Hematology, the 307 Hospital, Beijing, P. R. China
| | - G. X. Liu
- Department of Radiation Medicine and Clinical Hematology, the 307 Hospital, Beijing, P. R. China
| | - Q. H. Man
- Department of Radiation Medicine and Clinical Hematology, the 307 Hospital, Beijing, P. R. China
| | - L. J. Qiu
- Department of Radiation Medicine and Clinical Hematology, the 307 Hospital, Beijing, P. R. China
| |
Collapse
|
71
|
Pei Y, Wei S, Yao B, Ma X, Yang Y, Yuan L, Li Q, Ji P, Hu S, Ji L. Evaluation of serum protein mass spectrometry technology to identify NSCLC patients with tumor response to gefitinib. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.3107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
72
|
Su SC, Lu YM, Zhang ZZ, Shan CX, Li BH, Shen DZ, Yao B, Zhang JY, Zhao DX, Fan XW. Optical properties of ZnMgO nanowalls grown by plasma-assisted molecular beam epitaxy. J Nanosci Nanotechnol 2010; 10:1681-1684. [PMID: 20355557 DOI: 10.1166/jnn.2010.2112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
ZnMgO nanowalls were prepared by plasma-assisted molecular beam epitaxy without a catalyst on c-Al2O3 substrate. The obtained nanowalls have preferred orientation along c axis. The nanowalls are about 10 to 20 nm in thickness and about 50 nm in height. Only Zn, Mg, O and Al signals are detected in the nanowalls from the energy dispersive spectroscopy (EDS). The Mg content is about 3% in ZnMgO nanowalls. The room temperature photoluminescence (PL) spectra shows the emission peak of the ZnMgO nanowalls at 3.346 eV. The origin of the ultraviolet emission is discussed with the help of temperature-dependent PL spectra. The ultraviolet emission band is free exiton recombination observed in the low temperature PL spectra (at 81 K). We also observe the free-to-acceptor (FA) emission of the ZnMgO nanowalls. The acceptor binding energy obtained from photoluminescence studies is about 123 meV. The results show that Mg doping leads to an increase of the acceptor binding energy. The possible growth mechanism of the ZnMgO nanowall networks was discussed.
Collapse
Affiliation(s)
- S C Su
- Key Laboratory of Excited State Processes, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun 130033, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
73
|
Alle A, Dembelle A, Yao B, Ado G. Distribution of Organochlorine Pesticides in Human Breast Milk and Adipose Tissue from Two Locations in Côte d’Ivoire. ACTA ACUST UNITED AC 2009. [DOI: 10.3923/ajaps.2009.456.463] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
74
|
Cui YX, Shi YC, Liu Q, Xia XY, Lu HY, Shao HF, Jia L, Yao B, Ge YF, Li XJ, Huang YF. A Case of Agonadism Associated With Y-Chromosome Rearrangement: Cytogenetic and Molecular Studies. ACTA ACUST UNITED AC 2009; 30:650-4. [DOI: 10.2164/jandrol.108.006353] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
75
|
Shmueli K, van Gelderen P, Yao B, de Zwart J, Fukunaga M, Duyn J. Quantitative Magnetic Susceptibility Mapping Overcomes the Orientation Dependence of Tissue MRI Phase Contrast. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)70113-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
76
|
Yao B, Bagnato F, Merkle H, van Gelderen P, Cantor FK, Ohayon J, McFarland H, Duyn JH. Exploring In-Vivo and Post-Mortem Multiple Sclerosis Lesions at 7T MRI with R2* and Phase Images. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)70122-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
77
|
|
78
|
Luo HY, Wang YR, Miao LH, Yang PL, Shi PJ, Fang CX, Yao B, Fan YL. Nesterenkonia alba sp. nov., an alkaliphilic actinobacterium isolated from the black liquor treatment system of a cotton pulp mill. Int J Syst Evol Microbiol 2009; 59:863-8. [DOI: 10.1099/ijs.0.003376-0] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
79
|
Affiliation(s)
- E. Assidjo
- Institut National Polytechnique Houphouët-Boigny, Côte d'Ivoire
| | - B. Yao
- Institut National Polytechnique Houphouët-Boigny, Côte d'Ivoire
| | - K. Kisselmina
- Institut National Polytechnique Houphouët-Boigny, Côte d'Ivoire
| | - D. Amané
- Institut National Polytechnique Houphouët-Boigny, Côte d'Ivoire
| |
Collapse
|
80
|
Zang CH, Liu YC, Mu R, Zhao DX, Zhang JY, Ma JG, Lu YM, Yao B, Shen DZ, Fan XW. Photoluminescence of ZnO nanocrystals embedded in BaF2 matrices by magnetron sputtering. J Nanosci Nanotechnol 2008; 8:1160-1164. [PMID: 18468116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
This paper describes ZnO nanocrystals embedded in BaF2 matrices by the magnetron sputtering method in an attempt to use fluoride as a shell layer to embed ZnO nanocrystals core. BaF2 is a wide-band gap material, and can confine carriers in the ZnO films. As a result, the exciton emission intensity should be enhanced. The sample was annealed at 773 K, and X-ray diffraction (XRD) results showed that ZnO nanocrystals with wurtzite structure were embedded in BaF2 matrices. Raman-scattering spectra also confirmed the formation of ZnO nanoparticles. Abnormal longitudinal-optical (LO) phonon-dominant multiphonon Raman scattering was observed in the sample. Room-temperature photoluminescence (PL) spectra showed an ultraviolet emission peak at 374 nm. The origin of the ultraviolet emission is discussed here with the help of temperature-dependent PL spectra. The ultraviolet emission band was a mixture of free exciton and bound exciton recombination observed in the low temperature PL spectra (at 77 K). Abnormal temperature dependence of ultraviolet near-band-edge emission-integrated intensity of the sample was observed. The band tail state was observed in the absorption spectra, illustrating that the impurity-related defects were caused by the shell of the BaF2 grain layer. For comparison, ZnO films on BaF2 substrates were also fabricated by the magnetron sputtering method, and the same measurement methods were used.
Collapse
Affiliation(s)
- C H Zang
- Key Laboratory of Excited State Process, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun 130033, People's Republic of China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
81
|
Abstract
AIMS This study was carried out to determine whether bacterial and ciliate populations in goat rumen vary significantly between different goat species living in the same environment. METHODS AND RESULTS Bacterial and ciliate communities in the rumen of three goat species were analysed at the molecular level using denaturing gradient gel electrophoresis. The microbial community varied considerably among goats living in the same environment. Interspecies variation in the bacterial population was noticeably greater than intraspecies variation. In contrast, there was considerable variation in the ciliate population among goats within the same species, and intraspecies similarities were no greater than those observed across species. CONCLUSIONS Because environmental factors and diets were identical for all goats, differences in bacterial populations reflect species-specific differences in rumen microbes. SIGNIFICANCE AND IMPACT OF THE STUDY Factors related to the host species have an important effect on determining the bacterial composition in the goat rumen.
Collapse
Affiliation(s)
- P J Shi
- Microbial Engineering Department, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China
| | | | | | | | | | | |
Collapse
|
82
|
Zhou L, Li CJ, Wang Y, Xia W, Yao B, Jin JY, Gui JF. Identification and characterization of a MBP isoform specific to hypothalamus in orange-spotted grouper (Epinephelus coioides). J Chem Neuroanat 2007; 34:47-59. [PMID: 17513086 DOI: 10.1016/j.jchemneu.2007.03.011] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2006] [Revised: 03/30/2007] [Accepted: 03/31/2007] [Indexed: 11/30/2022]
Abstract
Myelin basic protein (MBP), as a major component of the myelin sheath, has been revealed to play an important role in forming and maintaining myelin structure in vertebrate nervous system. In teleost, hypothalamus is an instinctive brain center and plays significant roles in many physiological functions, such as energy metabolism, growth, reproduction, and stress response. In comparison with other MBP identified in vertebrates, a smallest MBP is cloned and identified from the orange-spotted grouper hypothalamic cDNA plasmid library in this study. RT-PCR analysis and Western blot detection indicate that the EcMBP is specific to hypothalamus, and expresses mainly in the tuberal hypothalamus in adult grouper. Immunofluorescence localization suggests that EcMBP should be expressed by oligodendrocytes, and the expressing cells should be concentrated in hypothalamus and the area surrounding hypothalamus, such as NPOpc, VC, DP, NLTm, and NDLI. The studies on EcMBP expression pattern and developmental behaviour in the brains of grouper embryos and larvae reveal that the EcMBP-expressing cells are only limited in a defined set of cells on the border of hypothalamus, and suggest that the EcMBP-expressing cells might be a subpopulation of oligodendrocyte progenitor cells. This study not only identifies a smallest MBP isoform specific to hypothalamus that can be used as a molecular marker of oligodendrocytes in fish, but also provides new insights for MBP evolution and cellular distribution.
Collapse
Affiliation(s)
- L Zhou
- State Key Laboratory of Freshwater Ecology and Biotechnology, Wuhan Center for Developmental Biology, Institute of Hydrobiology, Chinese Academy of Sciences, Graduate School of the Chinese Academy of Sciences, Wuhan, China
| | | | | | | | | | | | | |
Collapse
|
83
|
Antonuk L, Zhao Q, El-Mohri Y, Du H, Behravan M, Wang Y, Weisfield R, Yao B, Street R. MO-E-L100J-01: Enhancement of Signal Performance Through Innovative Pixel Design for Indirect Detection Active Matrix Flat-Panel Arrays. Med Phys 2007. [DOI: 10.1118/1.2761257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
84
|
|
85
|
Xu HR, Lu JC, Chen F, Huang YF, Yao B, Lu NQ. The effect of chymotrypsin on the determination of total alpha-glucosidase activity in seminal plasma and the correlation between alpha-glucosidase level and semen parameters. ACTA ACUST UNITED AC 2006; 52:441-6. [PMID: 17050325 DOI: 10.1080/01485010600822689] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
To evaluate the effect of chymotrypsin on the examination of alpha-glucosidase activity in seminal plasma, thirty-nine samples of fresh liquefied semen with or without chymotrypsin and forty-eight samples of fresh un-liquefied semen with chymotrypsin were determined for the total alpha-glucosidase activity in seminal plasma. The total alpha-glucosidase level of each sample was assayed by the method of glucose oxidase. The correlations between alpha-glucosidase level and semen parameters, including semen volume, pH, sperm concentration, grade a and b motility and total motility, were analyzed with SPSS 11.0 software. The results showed that chymotrypsin had no effect on seminal alpha-glucosidase activity determination. Chymotrypsin could improve the liquefaction for un-liquefied semen, and there was no significant difference of alpha-glucosidase activity between liquefied and un-liquefied semen samples. There were significantly positive correlations between seminal alpha-glucosidase activity (U/ml) and sperm concentration (r = 0.338, p = 0.015) and between total alpha-glucosidase activity (U/ejaculate) and semen volume (r = 0.677, p = 0.000). However, there was no significant correlation between alpha-glucosidase level (U/ml) and semen volume, pH, sperm motility or grade a and b motility (r = -0.234 approximately 0.077, p = 0.099 approximately 0.993). The data indicated that chymotrypsin could be added into the un-liquefied semen samples for alpha-glucosidase activity determination, and there were different correlations between seminal alpha-glucosidase level and various semen parameters.
Collapse
Affiliation(s)
- H-R Xu
- Department of Reproduction and Genetics, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, PR China
| | | | | | | | | | | |
Collapse
|
86
|
Yang HM, Yao B, Meng K, Wang YR, Bai YG, Wu NF. Introduction of a disulfide bridge enhances the thermostability of a Streptomyces olivaceoviridis xylanase mutant. J Ind Microbiol Biotechnol 2006; 34:213-8. [PMID: 17139507 DOI: 10.1007/s10295-006-0188-y] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2006] [Accepted: 11/03/2006] [Indexed: 10/23/2022]
Abstract
Substitution of the N-terminus of Streptomyces olivaceoviridis xylanase XYNB to generate mutant TB has been previously shown to increase the thermostability of the enzyme. To further improve the stability of this mutant, we introduced a disulfide bridge (C109-C153) into the TB mutant, generating TS. To assess the effect of the disulfide bridge in the wild-type enzyme, the S109C-N153C mutation was also introduced into XYNB, resulting in XS. The mutants were expressed in Pichia pastoris, the recombinant enzymes were purified, and the effect of temperature and pH on enzymatic activity was characterized. Introduction of the disulfide bridge (C109-C153) into XYNB (XS variant) and TB (TS variant) increased the thermostability up to 2.8-fold and 12.4-fold, respectively, relative to XYNB, after incubation at 70 degrees C, pH 6.0, for 20 min. In addition, a synergistic effect of the disulfide bridge and the N-terminus replacement was observed, which extended the half-life of XYNB from 3 to 150 min. Moreover, XS and TS displayed better resistance to acidic conditions compared with the respective enzymes that did not contain a disulfide bridge.
Collapse
Affiliation(s)
- H M Yang
- Feed Research Institute, Chinese Academy of Agricultural Sciences, 100081 Beijing, China
| | | | | | | | | | | |
Collapse
|
87
|
Jiang J, Yao B, Wason AM. A genetic algorithm design for microcalcification detection and classification in digital mammograms. Comput Med Imaging Graph 2006; 31:49-61. [PMID: 17049809 DOI: 10.1016/j.compmedimag.2006.09.011] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2005] [Revised: 09/06/2006] [Accepted: 09/11/2006] [Indexed: 11/17/2022]
Abstract
In this paper, we propose a genetic algorithm design to automatically classify and detect micocalcification clusters in digital mammograms. The proposed GA technique is characterised by transforming input images into a feature domain, where each pixel is represented by its mean and standard deviation inside a surrounding window of size 9 x 9 pixel. In the feature domain, chromosomes are constructed to populate the initial generation and further features are extracted to enable the proposed GA to search for optimised classification and detection of microcalcification clusters via regions of 128 x 128 pixels. Extensive experiments show that the proposed GA design is able to achieve high performances in microcalcification classification and detection, which are measured by ROC curves, sensitivity against specificity, areas under ROC curves and benchmarked by existing representative techniques.
Collapse
Affiliation(s)
- J Jiang
- University of Bradford, School of Informatics, Richmond Road, Bradford BD7 1DP, United Kingdom.
| | | | | |
Collapse
|
88
|
Lisak RP, Benjamins JA, Bealmear B, Yao B, Land S, Nedelkoska L, Skundric D. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures. Mult Scler 2006; 12:149-68. [PMID: 16629418 DOI: 10.1191/135248506ms1251oa] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Cytokines secreted within the central nervous system (CNS) are important in the development of multiple sclerosis (MS) lesions. The balance between Th1, monocyte/macrophage (M/M) and Th2 cytokines in the CNS may be pivotal in determining the outcome of lesion development. We examined the effects of mixtures of cytokines on gene expression by CNS glial cells, as mixtures of cytokines are present in MS lesions, which in turn contain mixtures of glial cells. In this initial analysis by gene array, we examined changes at 6 hours to identify early changes in gene expression that represent primary responses to the cytokines. Rat glial cells were incubated with mixtures of Th1, M/M and Th2 cytokines for 6 hours and examined for changes in early gene expression employing microarray gene chip technology. A minimum of 814 genes were differentially regulated by one or more of the cytokine mixtures in comparison to controls, including changes in expression in a large number of genes for immune system-related proteins. Expression of the proteins for these genes likely influences development and inhibition of MS lesions as well as protective and regenerative processes. Analysing gene expression for the effects of various combinations of exogenous cytokines on glial cells in the absence of the confounding effects of inflammatory cells themselves should increase our understanding of cytokine-induced pathways in the CNS.
Collapse
Affiliation(s)
- R P Lisak
- Department of Neurology, Wayne State University, Detroit, MI 48201, USA.
| | | | | | | | | | | | | |
Collapse
|
89
|
Vandebroek A, Gaede B, Altintas S, Smith K, Yao B, Schupp M, Bastit L. A randomized open-label study of darbepoetin alfa administered every 3 weeks with or without parenteral iron in anemic subjects with nonmyeloid malignancies receiving chemotherapy. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.8612] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8612 Background: Patients (pts) with cancer receiving chemotherapy often have chemotherapy-induced anemia (CIA) and reduced quality of life. Darbepoetin alfa (DA) is an erythropoiesis-stimulating agent (ESA) that can effectively treat CIA when administered once every 3 weeks (Q3W). In patients with CIA, limited data in the literature suggest that administration of intravenous (IV) iron with ESA therapy may increase clinical response. Methods: This randomized, multicenter, open-label, 16-week study evaluated the safety and efficacy of DA 500 mcg administered Q3W using the SureClick injection device in pts with CIA (Hb < 11 g/dL) who received either IV iron or standard practice for iron administration (oral iron or no iron). The dose of IV iron was 200 mcg administered either Q3W with DA Q3W or, if required, as 2 doses (200 mcg total) within a 3-week period. Pts who received ≥ 1 dose of DA and who completed the 16-week study period by October 19, 2005 are included in this interim analysis (planned sample size = 400 pts). Accrual will have finished by conference time. Randomization was stratified by tumor type and baseline (BL) Hb (< 10 or ≥ 10 g/dL). The incidence of adverse events and serious adverse events, in particular embolic/thrombotic events, was summarized. Efficacy endpoints were estimated using the crude % of pts (95% CI). Hb values within 28 days of a transfusion were not included in any efficacy analysis. Results: Of the 114 pts included in this interim analysis, 65% were women, 99% were Caucasian, the mean (SD) age was 60 years (12), and 26% had lung or gynecological tumors; study endpoints are shown in the table. Conclusions: Based on the interim results, the safety profile for pts receiving DA 500 mcg Q3W with IV iron appears to be comparable to pts receiving DA 500 mcg Q3W with oral iron or no iron. The % pts who achieved the target Hb (≥ 11 g/dL) appeared higher, and the % pts who required transfusions appeared lower, in the group receiving IV iron. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- A. Vandebroek
- Ziekenhuis Network Antwerpen, Middelheim, Hem-onc, Antwerpen, Belgium; Schwerpunktpraxis Hämatologie/Onkologie, Hannover, Germany; Universitair Ziekenhuis Antwerpen, Edegem, Belgium; Amgen GmbH, Zug, Switzerland; Amgen Ltd, Cambridge, United Kingdom; Centre Frédéric Joliot, Rouen, France
| | - B. Gaede
- Ziekenhuis Network Antwerpen, Middelheim, Hem-onc, Antwerpen, Belgium; Schwerpunktpraxis Hämatologie/Onkologie, Hannover, Germany; Universitair Ziekenhuis Antwerpen, Edegem, Belgium; Amgen GmbH, Zug, Switzerland; Amgen Ltd, Cambridge, United Kingdom; Centre Frédéric Joliot, Rouen, France
| | - S. Altintas
- Ziekenhuis Network Antwerpen, Middelheim, Hem-onc, Antwerpen, Belgium; Schwerpunktpraxis Hämatologie/Onkologie, Hannover, Germany; Universitair Ziekenhuis Antwerpen, Edegem, Belgium; Amgen GmbH, Zug, Switzerland; Amgen Ltd, Cambridge, United Kingdom; Centre Frédéric Joliot, Rouen, France
| | - K. Smith
- Ziekenhuis Network Antwerpen, Middelheim, Hem-onc, Antwerpen, Belgium; Schwerpunktpraxis Hämatologie/Onkologie, Hannover, Germany; Universitair Ziekenhuis Antwerpen, Edegem, Belgium; Amgen GmbH, Zug, Switzerland; Amgen Ltd, Cambridge, United Kingdom; Centre Frédéric Joliot, Rouen, France
| | - B. Yao
- Ziekenhuis Network Antwerpen, Middelheim, Hem-onc, Antwerpen, Belgium; Schwerpunktpraxis Hämatologie/Onkologie, Hannover, Germany; Universitair Ziekenhuis Antwerpen, Edegem, Belgium; Amgen GmbH, Zug, Switzerland; Amgen Ltd, Cambridge, United Kingdom; Centre Frédéric Joliot, Rouen, France
| | - M. Schupp
- Ziekenhuis Network Antwerpen, Middelheim, Hem-onc, Antwerpen, Belgium; Schwerpunktpraxis Hämatologie/Onkologie, Hannover, Germany; Universitair Ziekenhuis Antwerpen, Edegem, Belgium; Amgen GmbH, Zug, Switzerland; Amgen Ltd, Cambridge, United Kingdom; Centre Frédéric Joliot, Rouen, France
| | - L. Bastit
- Ziekenhuis Network Antwerpen, Middelheim, Hem-onc, Antwerpen, Belgium; Schwerpunktpraxis Hämatologie/Onkologie, Hannover, Germany; Universitair Ziekenhuis Antwerpen, Edegem, Belgium; Amgen GmbH, Zug, Switzerland; Amgen Ltd, Cambridge, United Kingdom; Centre Frédéric Joliot, Rouen, France
| |
Collapse
|
90
|
Zhang R, Tian L, Chen LJ, Xiao F, Hou JM, Zhao X, Li G, Yao B, Wen YJ, Li J, Zhang L, Chen XC, Luo F, Peng F, Jiang Y, Wei YQ. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma. Gene Ther 2006; 13:1263-71. [PMID: 16672984 DOI: 10.1038/sj.gt.3302756] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
MIG (monokine induced by interferon-gamma) is a CXC chemokine ligand (CXCL9) that can potently inhibit angiogenesis, and displays thymus-dependent antitumor effects. The effectiveness of a treatment combining gene therapy with plasmid-borne MIG (pORF-MIG) and low-dose cisplatin chemotherapy was determined using colon carcinoma (CT26) and Lewis lung carcinoma (LL/2c) murine models. The program was carried out via intramuscular delivery of pORF-MIG at 100 mug/mouse twice a week for 4 weeks, and/or intraperitoneal delivery of cisplatin at 0.6 mg/kg/mouse every 3 days for 48 days. Tumor volume and survival time were evaluated after treatment. CD31 immunohistochemical staining in tumor tissues and alginate capsule models in vivo was used to evaluate angiogenesis. Induction of apoptosis and cytotoxic T-lymphocyte (CTL) activity were also assessed. The combination of pORF-MIG and low-dose cisplatin produced significant antitumor activity, with complete tumor regression in 4/10 of CT26 colon carcinomas and 3/10 of LL/2c lung carcinomas, low vascularity, in alginate capsules, apparently degraded tumor microvessel density, and increased induction of apoptotic and CTL activities compared with either treatment alone. This study suggests that the combination of pORF-MIG plus cisplatin augments the inhibition of angiogenesis and the induction of apoptosis or CTL activity, all of which enhance antitumor activity. These findings may prove useful in further explorations of the application of combinatorial approaches to the treatment of solid tumors.
Collapse
MESH Headings
- Animals
- Antineoplastic Agents/therapeutic use
- Apoptosis
- Carcinoma/drug therapy
- Carcinoma/therapy
- Carcinoma, Lewis Lung/blood supply
- Carcinoma, Lewis Lung/drug therapy
- Carcinoma, Lewis Lung/therapy
- Chemokine CXCL9
- Chemokines, CXC/genetics
- Cisplatin/therapeutic use
- Colonic Neoplasms/blood supply
- Colonic Neoplasms/drug therapy
- Colonic Neoplasms/therapy
- Combined Modality Therapy
- Genetic Engineering
- Genetic Therapy/methods
- Injections, Intramuscular
- Injections, Intraperitoneal
- Lymphocyte Activation
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Neoplasms, Experimental/blood supply
- Neoplasms, Experimental/drug therapy
- Neoplasms, Experimental/therapy
- Neovascularization, Pathologic
- Oncolytic Virotherapy/methods
- Plasmids/administration & dosage
- Random Allocation
- T-Lymphocytes, Cytotoxic/immunology
Collapse
Affiliation(s)
- R Zhang
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
91
|
Jiao SJ, Lu YM, Shen DZ, Zhang ZZ, Li BH, Zhang JY, Yao B, Liu YC, Fan XW. Ultraviolet electroluminescence of ZnO based heterojunction light emitting diode. ACTA ACUST UNITED AC 2006. [DOI: 10.1002/pssc.200564641] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
92
|
Li Y, Yao B, Jin J, Song Y, Liu X, Shi Y, Lu L, Yu Z. Radiotherapy as Primary Treatment for Localized Stage IE and IIE Nasal NK/T Cell Lymphoma. Int J Radiat Oncol Biol Phys 2005. [DOI: 10.1016/j.ijrobp.2005.07.712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
93
|
Liu JZ, Yang Q, Yao B, Brown RW, Yue GH. Linear correlation between fractal dimension of EEG signal and handgrip force. Biol Cybern 2005; 93:131-40. [PMID: 16028075 DOI: 10.1007/s00422-005-0561-3] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/03/2005] [Accepted: 03/18/2005] [Indexed: 05/03/2023]
Abstract
Fractal dimension (FD) has been proved useful in quantifying the complexity of dynamical signals in biology and medicine. In this study, we measured FDs of human electroencephalographic (EEG) signals at different levels of handgrip forces. EEG signals were recorded from five major motor-related cortical areas in eight normal healthy subjects. FDs were calculated using three different methods. The three physiological periods of handgrip (command preparation, movement and holding periods) were analyzed and compared. The results showed that FDs of the EEG signals during the movement and holding periods increased linearly with handgrip force, whereas FD during the preparation period had no correlation with force. The results also demonstrated that one method (Katz's) gave greater changes in FD, and thus, had more power in capturing the dynamic changes in the signal. The linear increase of FD, together with results from other EEG and neuroimaging studies, suggest that under normal conditions the brain recruits motor neurons at a linear progress when increasing the force.
Collapse
Affiliation(s)
- J Z Liu
- Department of Biomedical Engineering, The Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
| | | | | | | | | |
Collapse
|
94
|
Yao B, Peng W, Santanam L, Van den Heuvel F, Burmeister J. SU-FF-T-163: Quantitative Verification of IMRT Intensity Maps Using An Amorphous Silicon Electronic Portal Imager. Med Phys 2005. [DOI: 10.1118/1.1997834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
95
|
Fayz B, Moldenhauer JS, Wang D, Zhao C, Yao B, Liu D, Weinsheimer S, Gardner L, Johnson A, Womble DD, Krawetz SA. LARALink: a web application for cytogenetic linkage analysis. Clin Genet 2005; 67:314-21. [PMID: 15733267 DOI: 10.1111/j.1399-0004.2005.00409.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Genomic and expression data have increased dramatically over the last several years. This is primarily due to the completion of the human genome project as well as an upsurge in the use of various high-throughput technologies. Recent attempts to correlate genomic and expression data have stimulated the scientific community to determine how this data can be used within a clinical setting (P Khatri et al., Genomics 2002: 79: 266; LJ van't Veer et al., Nature 2002: 415: 530). LARALink (Loci Analysis for Rearrangements Link) is a database-driven web application that utilizes several public datasets to analyze clinical cytogenetic data to identify candidate genes. LARALink allows UniGene clusters or single-nucleotide polymorphisms (SNPs) to be queried for multiple patients by cytoband, chromosome marker, or base pair. The results can be further refined with the use of an anatomical site, developmental stage, pathology, or cell-type expression filter. Once a set of UniGene clusters (expressed genes) has been identified either for a single patient or for a shared region among multiple patients, the expression-distribution profile, expressed sequence tags (ESTs), or online mendelian inheritance in man (OMIM) entries are displayed. The utility of this tool is shown by its application to both research and clinical medicine. LARALink is a public resource available at: http://www.laralink.bioinformatics.wayne.edu:8080/unigene.
Collapse
Affiliation(s)
- B Fayz
- Bioinformatics Facility, University of Pennsylvania, Philadelphia, PA, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
96
|
Vadhan-Raj S, Mirtsching B, Gregory SA, Hong J, Fessen M, Yao B, Rossi G, Blayney D. Baseline (BL) covariates of response to darbepoetin alfa (DA) every 2 weeks (Q2W) in patients (pts) with chemotherapy-induced anemia (CIA). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.8061] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. Vadhan-Raj
- M. D. Anderson Cancer Center, Houston, TX; Center for Oncology Research and Treatment, Dallas, TX; The Rush University Medical Center, Chicago, IL; Chesapeake Oncology-Hematology Associates, Baltimore, MD; Hutchinson Clinic, PA, Hutchinson, KS; Amgen Inc, Thousand Oaks, CA; Wilshire Oncology Medical Group, Pomona, CA
| | - B. Mirtsching
- M. D. Anderson Cancer Center, Houston, TX; Center for Oncology Research and Treatment, Dallas, TX; The Rush University Medical Center, Chicago, IL; Chesapeake Oncology-Hematology Associates, Baltimore, MD; Hutchinson Clinic, PA, Hutchinson, KS; Amgen Inc, Thousand Oaks, CA; Wilshire Oncology Medical Group, Pomona, CA
| | - S. A. Gregory
- M. D. Anderson Cancer Center, Houston, TX; Center for Oncology Research and Treatment, Dallas, TX; The Rush University Medical Center, Chicago, IL; Chesapeake Oncology-Hematology Associates, Baltimore, MD; Hutchinson Clinic, PA, Hutchinson, KS; Amgen Inc, Thousand Oaks, CA; Wilshire Oncology Medical Group, Pomona, CA
| | - J. Hong
- M. D. Anderson Cancer Center, Houston, TX; Center for Oncology Research and Treatment, Dallas, TX; The Rush University Medical Center, Chicago, IL; Chesapeake Oncology-Hematology Associates, Baltimore, MD; Hutchinson Clinic, PA, Hutchinson, KS; Amgen Inc, Thousand Oaks, CA; Wilshire Oncology Medical Group, Pomona, CA
| | - M. Fessen
- M. D. Anderson Cancer Center, Houston, TX; Center for Oncology Research and Treatment, Dallas, TX; The Rush University Medical Center, Chicago, IL; Chesapeake Oncology-Hematology Associates, Baltimore, MD; Hutchinson Clinic, PA, Hutchinson, KS; Amgen Inc, Thousand Oaks, CA; Wilshire Oncology Medical Group, Pomona, CA
| | - B. Yao
- M. D. Anderson Cancer Center, Houston, TX; Center for Oncology Research and Treatment, Dallas, TX; The Rush University Medical Center, Chicago, IL; Chesapeake Oncology-Hematology Associates, Baltimore, MD; Hutchinson Clinic, PA, Hutchinson, KS; Amgen Inc, Thousand Oaks, CA; Wilshire Oncology Medical Group, Pomona, CA
| | - G. Rossi
- M. D. Anderson Cancer Center, Houston, TX; Center for Oncology Research and Treatment, Dallas, TX; The Rush University Medical Center, Chicago, IL; Chesapeake Oncology-Hematology Associates, Baltimore, MD; Hutchinson Clinic, PA, Hutchinson, KS; Amgen Inc, Thousand Oaks, CA; Wilshire Oncology Medical Group, Pomona, CA
| | - D. Blayney
- M. D. Anderson Cancer Center, Houston, TX; Center for Oncology Research and Treatment, Dallas, TX; The Rush University Medical Center, Chicago, IL; Chesapeake Oncology-Hematology Associates, Baltimore, MD; Hutchinson Clinic, PA, Hutchinson, KS; Amgen Inc, Thousand Oaks, CA; Wilshire Oncology Medical Group, Pomona, CA
| |
Collapse
|
97
|
Abstract
OBJECTIVES The aim of this study is: to emphasize the difficulties of diagnosing genito-urinary tuberculosis because of its non specific symptoms; to incite the physician to seek it more frequently. MATERIAL AND METHOD Five cases of genito-urinary tuberculosis have been diagnosed within a 10-years period and included in a retrospective study. RESULTS We found one location in the kidney and one location in the bladder with 2 women diagnosed by repeated urianalysis and 3 cases of location in epididymis diagnosed after surgery. CONCLUSION Symptoms of genito-urinary tuberculosis are misleading, pathologic findings are taking a more and more important place in the diagnosis, which the new techniques of serologic tests will surely improve.
Collapse
Affiliation(s)
- K Dje
- Service d'urologie, CHU de Treichville, 01 BP 5685 Abidjan 01, Côte-D'Ivoire.
| | | | | | | |
Collapse
|
98
|
Abstract
The authors report a case of pheochromocytoma of the bladder revealed by an important gross hematuria with shock. The diagnosis has been established by the pathologist after a partial cystectomy. This location mimmicks a bladder tumor. The diagnosis is difficult; conservative surgery is the rule.
Collapse
Affiliation(s)
- K Djè
- Service d'urologie, CHU de Treichville, Cote d'Ivoire.
| | | | | | | | | |
Collapse
|
99
|
Yao B, Gnagne M, Sery F, Dossou C, Gnanazan G. [Treatment of vesicovaginal fistulas using the musculofascial flap of the levator ani muscle: 26 case reports]. Ann Urol (Paris) 2003; 37:108-12. [PMID: 12872599 DOI: 10.1016/s0003-4401(03)00043-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
OBJECTIVE The authors reported the preliminary results of levator ani muscle flap in the treatment of vesicovaginal fistula. MATERIALS AND METHODS Twenty-six patients whose age varied between 13 and 18 years (mean: 30 years) are selected. All the patients are treated by the vaginal approach using the part of superficial rectal fibers of the levator ani muscle. RESULTS Among the 26 patients, 14 are free after the first cure of vesicovaginal fistula (54%), and 4 patients (15%), after the treatment of some complications. CONCLUSION The musculofascial levator ani flap with its vascular pedicle and its mobilisation can successfully close the vesicovaginal fistula. The preliminary results obtained (88%) tie up with that previously described in the literature.
Collapse
Affiliation(s)
- B Yao
- Service de chirurgie-urologie, CHU de Treichville, 04 BP 265, Abidjan 04, Côte d'Ivoire.
| | | | | | | | | |
Collapse
|
100
|
Brizel D, Le Q, Rosenthal D, Meredith R, Brizel H, Heard R, Yao B, Eng T, Sailer S, Chen Y, Murphy B, Mendenhall W. Phase 2 study of recombinant human keratinocyte growth factor (rHuKGF) in head & neck cancer treated with standard (SRT) or hyperfractionated irradiation (HRT) & concurrent chemotherapy (CT). Int J Radiat Oncol Biol Phys 2002. [DOI: 10.1016/s0360-3016(02)03551-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|